ArticleJournal of translational medicine2026

A brain-penetrant chimeric protein combines direct glioma targeting with myeloid cell-mediated immune reprogramming.

Elisabetta Mori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.